Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kuentz

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Annales De Medecine Interne|January 1, 1980
[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]B Brun, Y Alaoui, M Kuentz, et al.
Blood|September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trialN C Gorin, B Coiffier, M Hayat, et al.
Cancer|November 1, 1989
Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remissionG Ganem, M Kuentz, F Bernaudin, et al.
American Journal of Clinical Oncology|October 1, 1989
Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosisC Haioun, P Gaulard, F Roudot-Thoraval, et al.
Bone Marrow Transplantation|April 1, 1993
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMTC Belanger, H Esperou-Bourdeau, P Bordigoni, et al.
Experimental Hematology|December 1, 1987
T-cell depletion of bone marrow transplants: assessment of standard immunological methods of quantificationB Autran, F Beaujean, C Pillier, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle OsseuseG Michel, E Gluckman, D Blaise, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Bone Marrow Transplantation|May 1, 1995
Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemiaF Beaujean, F Bernaudin, M Kuentz, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Annales De Medecine Interne|January 1, 1980
[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]B Brun, Y Alaoui, M Kuentz, et al.
Blood|September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trialN C Gorin, B Coiffier, M Hayat, et al.
Cancer|November 1, 1989
Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remissionG Ganem, M Kuentz, F Bernaudin, et al.
American Journal of Clinical Oncology|October 1, 1989
Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosisC Haioun, P Gaulard, F Roudot-Thoraval, et al.
Bone Marrow Transplantation|April 1, 1993
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMTC Belanger, H Esperou-Bourdeau, P Bordigoni, et al.
Experimental Hematology|December 1, 1987
T-cell depletion of bone marrow transplants: assessment of standard immunological methods of quantificationB Autran, F Beaujean, C Pillier, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle OsseuseG Michel, E Gluckman, D Blaise, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Bone Marrow Transplantation|May 1, 1995
Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemiaF Beaujean, F Bernaudin, M Kuentz, et al.
Pageof 10